Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 1Hypertension 1Diabetes Mellitus 1Depressive Disorder, Major 1Depression 1Cardiovascular Diseases 1

Interventions

Nutrition Assessment 2Fatty Acids, Omega-3 2Vorinostat 1Vitamin E 1Tumor Necrosis Factor Inhibitors 1Therapeutics 1Sugars 1Rosuvastatin Calcium 1Resistance Training 1Omeprazole 1Naproxen 1Methods 1Liraglutide 1Jogging 1Geritol 1Fish Oils 1Febuxostat 1Desvenlafaxine Succinate 1Colchicine 1Cholecalciferol 1Chocolate 1Bortezomib 1Atorvastatin 1Aspirin 1Antirheumatic Agents 1Allopurinol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Cardiovascular Diseases × Desvenlafaxine Succinate × Clear all
NCT01803711 2017-12-27

Omega 3 FA Supplements as Augmentation in the Treatment of Depression

UConn Health

Phase 2/3 Terminated
6 enrolled 4 charts

Cardiovascular Diseases, Depression, Depressive Disorder, Major, Diabetes Mellitus, Hypertension, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡